| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 297.96 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Introduction: Liver steatosis measurement by controlled attenuation parameter (CAP) is a noninvasive method for diagnosing steatosis1.
Plasma caspase-generated cytokeratin-18 fragments (CK-18) have been proposed as a non-invasive alternative for the diagnosis of NAFLD, especially NASH2.
Aims: compare CK-18 serum levels in apparently healthy individuals with and without steatosis.
Descrição
Palavras-chave
Determinantes Imunológicos em Doenças Crónicas Hepatic Steatosis
